IP Library Granted Patent US 9,283,064
Granted Patent B2
US 9,283,064 · App. 14/743,259 · Granted Mar 15, 2016

Methods and systems for treatment of prolapse

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,064
App. No.
14/743,259
Granted
Mar 15, 2016
Kind
B2
Abstract

Described are implants, tools, and related methods, for use in pelvic surgery to treat conditions such as prolapse, including embodiments of methods that involve a tissue path above the arcus tendineus.

Claims (34)

1. A method of supporting posterior vaginal tissue, the method comprising:

providing an implant comprising a tissue support portion and an extension portion extending from the tissue support portion,

creating an incision,

contacting the support portion with posterior vaginal tissue,

producing a tissue path that passes between a position of the tissue support portion and a region of an arcus tendineus, wherein the region of the arcus tendineus comprises a region from 2 centimeters above the arcus tendineus to 2 centimeters below the arcus tendineus and between an ischial spine and a distance 3 centimeters anterior to the ischial spine,

wherein the tissue path passes below the arcus tendineus through an iliococcygeus muscle, wraps around the arcus tendineus to a location above the arcus tendineus, through an obturator internus muscle, and back to a region of the pelvic floor, and

extending the extension portion through the tissue path.

2. The method of claim 1 , comprising treating a condition selected from the group consisting of enterocele, rectocele, apical prolapse, and vault prolapse.

3. The method of claim 1 , wherein the region of the arcus tendineus further includes the region between the arcus tendineus and 1 centimeter above the arcus tendineus, and between the ischial spine and a distance 1 centimeter anterior to the ischial spine.

4. The method of claim 1 , wherein a distal end of the extension portion is sutured to the pelvic floor.

5. The method of claim 1 , wherein the tissue path does not extend to an external incision.

6. The method of claim 1 , wherein the extension portion is passed through an external incision.

7. The method of claim 1 , wherein an incision is a perirectal incision.

8. A pelvic implant assembly comprising an implant and an insertion tool,

the implant comprising

a tissue support portion,

elongate extension portions extending from the tissue support portion, and

a dilator located at a distal end of each elongate extension portion, the dilator comprising a curve having a radius of curvature in the range of from 0.5-1.5 centimeters, a sharp tip at a distal end, and an opening at a proximal end, the opening designed and adapted to fit and removably engage a distal end of the insertion tool.

9. The pelvic implant assembly of claim 8 , wherein the implant is a mesh strip.

10. The pelvic implant assembly of claim 8 , wherein the implant has a length sufficient to extend from a region of an arcus tendineus on a first side of a patient to a region of an arcus tendineus on a second side of the patient.

11. The pelvic implant assembly of claim 8 , wherein the tissue support portion has a width greater than a width of the extension portions.

12. The pelvic implant assembly of claim 8 , wherein the implant includes a removable sheath that can cover one of the extension portions.

13. The pelvic implant assembly of claim 8 , wherein the insertion tool comprises a handle and a longitudinally extending shaft, wherein a proximal end of the extending shaft extends from the handle and a distal end of the extending shaft comprises a radius of curvature.

14. The pelvic implant assembly of claim 13 , wherein the dilator has a radius of curvature that matches the radius of curvature of the insertion tool.

15. The pelvic implant assembly of claim 13 , wherein the insertion tool is configured to push the dilator through tissue.

16. The pelvic implant assembly of claim 8 , wherein the insertion tool comprises a substantially straight shaft.

17. The pelvic implant assembly of claim 8 , wherein the insertion tool comprises a curved distal end, the curved portion comprising a radius of curvature in the range of from 0.5-1.5 centimeters.

18. A pelvic implant assembly comprising an implant and a first and second insertion tools,

the implant comprising

a tissue support portion,

a first elongate extension portion extending from an end of the tissue support portion and a second elongate extension portion extending from an opposite end of the tissue support portion, and

a first dilator located at a distal end of the first extension portion and a second dilator located at a distal end of the second extension portion, each dilator comprising a sharp tip at a distal end and an opening at a proximal end, the opening designed and adapted to engage a distal end of the first and second insertion tools; and wherein

each insertion tool comprises a shaft, a handle, and a curved distal end, the curved distal end comprising a radius of curvature in the range of from 0.5-1.5 centimeters, and the curved distal end being capable of engaging one of the dilators and pushing the dilator through tissue.

19. The pelvic implant assembly of claim 18 comprising a first suture extending along a length of the first extension portion and a second suture extending along a length of the second extension portion.

Assignments (7)
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: ASTORA WOMEN’S HEALTH, LLC
To: ENDO USA, INC.
Reel/Frame 067202/0768 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →